NEW YORK (GenomeWeb News) — Tm Bioscience yesterday said the US Navy plans to test its ID-Tag respiratory viral panel for its effectiveness as a warning against the threat of a viral pandemic.  
 
The Navy will use this panel in a surveillance program in South East Asia, to detect and identify influenzas, including avian flu. Tm Bio said the test is designed to provide results within six hours.
 
Financial terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.